NIR-activated multifunctional agents for the combined application in cancer imaging and therapy

Многофункциональные агенты, активируемые в ближней инфракрасной области, для комбинированного применения в визуализации и терапии рака
J. Dąbrowski, Paweł Repetowski, Marta Warszyńska, Janusz M. Dąbrowski
2024-11-22

NIR-activated agentscancer imagingcancer therapycombined imaging and therapymultifunctional agents
Anticancer therapies that combine both diagnostic and therapeutic capabilities hold significant promise for enhancing treatment efficacy and patient outcomes. Among these, agents responsive to near-infrared (NIR) photons are of particular interest due to their negligible toxicity and multifunctionality. These compounds are not only effective in photodynamic therapy (PDT), but also serve as contrast agents in various imaging modalities, including fluorescence and photoacoustic imaging. In this review, we explore the photophysical and photochemical properties of NIR-activated porphyrin, cyanine, and phthalocyanines derivatives as well as aggregation-induced emission compounds, highlighting their application in synergistic detection, diagnosis, and therapy. Special attention is given to the design and optimization of these agents to achieve high photostability, efficient NIR absorption, and significant yields of fluorescence, heat, or reactive oxygen species (ROS) generation depending on the application. Additionally, we discuss the incorporation of these compounds into nanocarriers to enhance their solubility, stability, and target specificity. Such nanoparticle-based systems exhibit improved pharmacokinetics and pharmacodynamics, facilitating more effective tumor targeting and broadening the application range to photoacoustic imaging and photothermal therapy. Furthermore, we summarize the application of these NIR-responsive agents in multimodal imaging techniques, which combine the advantages of fluorescence and photoacoustic imaging to provide comprehensive diagnostic information. Finally, we address the current challenges and limitations of photodiagnosis and phototherapy and highlight some critical barriers to their clinical implementation. These include issues related to their phototoxicity, limited tissue penetration, and potential off-target effects. The review concludes by highlighting future research directions aimed at overcoming these obstacles, with a focus on the development of next-generation agents and platforms that offer enhanced therapeutic efficacy and imaging capabilities in the field of cancer treatment.
1
Agents enable simultaneous diagnostic imaging and therapeutic action when activated by NIR light.
2
Developed near-infrared (NIR)-activated multifunctional agents that combine cancer imaging and therapy in a single platform.
3
Multifunctional agents can be used for combined phototherapeutic treatment and imaging-guided cancer management.
4
NIR activation provides deeper tissue penetration and spatial control for both imaging and therapy applications.

NIR-activated multifunctional agents for cancer applications

Combined cancer imaging and therapy performance and capabilities of NIR-activated multifunctional agents

Publication Details
Publication Date
2024-11-22
Journal
Publisher
ISSN
Cited by
46
Access Type
Author Information
Authors
J. Dąbrowski
Paweł Repetowski
Marta Warszyńska
Janusz M. Dąbrowski
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%